Post Traumatic Stress Disorder Trials Should Use Fixed Dose, Committee Says
Executive Summary
Sponsors seeking a post traumatic stress disorder indication should conduct fixed-dose studies, FDA's Psychopharmacologic Drugs Advisory Committee advised during its Oct. 8 review of Pfizer's Zoloft.You may also be interested in...
Zoloft PTSD Claim Clears FDA Cmte.; More Studies In Men Sought
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: